Worth reading
51Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Mixed performance
Direction inferred from the company’s description.Scale
-4450
¥ million (year-on-year change in operating profit)Wording
Conditional
How definitive the wording is.Results for this period
Full year2024年10月1日〜2025年9月30日ConsolidatedJapanese GAAPNet Sales49,174Millions of yenYear on year +15.8%Progress 95.1%
Operating profit6,162Millions of yenYear on year -41.9%Progress 162.2%
Ordinary income6,343Millions of yenYear on year -39.9%Progress 192.2%
Net income attributable to owners of the parent3,660Millions of yenYear on year -50.8%Progress 174.3%
The width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
Net income per share¥37.52
Operating Margin12.5%
Financial position at period-end
Total assets83,947Millions of yen
of which net assets 36,132 Millions of yenEquity ratio 43.0%vs. prior year-end -3.3pt
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Cash inflows and outflows
Operating+6,025
Investment-10,427
Financials+6,365
Net change+1,963
Stacked from zero: upward is an increase in cash, downward a decrease (in Millions of yen).The net change represented by the dotted line is the total of three items, calculated from figures provided by the company.
Cash and cash equivalents at end of period10,833 Millions of yen
Outlook and shareholder returns
Full-year earnings forecast
Net Sales51,700 Millions of yen (YoY +5.1%)
Operating profit3,800 Millions of yen (YoY -38.3%)
Ordinary income3,300 Millions of yen (YoY -48.0%)
Net income2,100 Millions of yen (YoY -42.6%)
Annual Dividend Forecast¥4 → ¥4（0.0%）
Payout ratio10.7%（2026年9月期予想18.6%）
Factors Behind Changes in Business Performance
医心館事業で新たに29事業所を開設し、1事業所を増床した一方、「医心館 本郷」を閉鎖し、「医心館 姫路」を事業譲渡した。次期計画では、新設施設の業績貢献と既存施設稼働率の回復を見込む一方、人件費増等の費用増や診療報酬改定影響を考慮している。
Disclosure regarding the going concern assumption
Not applicable.
Change in accounting policy
基準改正に伴う変更 Yesそれ以外の変更 No見積りの変更 No修正再表示 No
Changes in the scope of consolidationNew Number of companies 1 / Company name 株式会社ミドリ / Excluded Number of companies 0 / Company name Not disclosed
Material subsequent eventsNot applicable.
Breakdown of extraordinary income (loss)Extraordinary income Insurance proceeds received 50 Millions of yen / Extraordinary loss Special investigation expenses and related costs 650 Millions of yen, Provision for litigation loss 11 Millions of yen, Other 46 Millions of yen
Depreciation and amortization2,753 Millions of yen
Availability of Supplementary Financial Results MaterialsYes
Availability of Financial Results BriefingEvent Yes / Subject person Institutional investors and analysts; individual investors
Issued Shares at Period-End98,112,000
Treasury Shares at Period-End578,157
| Item | Details |
|---|---|
| Fiscal Period Classification | Full year |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 2024年10月1日〜2025年9月30日 |
| Net Sales | 49,174 Millions of yen (YoY +15.8%) |
| Operating profit | 6,162 Millions of yen (YoY -41.9%) |
| Ordinary income | 6,343 Millions of yen (YoY -39.9%) |
| Profit attributable to owners of the parent | 3,660 Millions of yen (YoY -50.8%) |
| Net income per share | ¥37.52 |
| Operating Margin | 12.5% |
| Equity ratio | End of the current fiscal period 43.0% / End of previous period 46.3% |
| Total assets | 83,947 Millions of yen |
| Net assets | 36,132 Millions of yen |
| Cash flows from operating activities | 6,025 Millions of yen |
| Cash flows from investing activities | -10,427 Millions of yen |
| Cash flows from financing activities | 6,365 Millions of yen |
| Cash and cash equivalents at end of period | 10,833 Millions of yen |
| Full-year earnings forecast | Net Sales 51,700 Millions of yen (YoY +5.1%) / Operating profit 3,800 Millions of yen (YoY -38.3%) / Ordinary income 3,300 Millions of yen (YoY -48.0%) / Net income 2,100 Millions of yen (YoY -42.6%) |
| Annual Dividend Forecast | ¥4 → ¥4（0.0%） |
| Payout ratio | 10.7%（2026年9月期予想18.6%） |
| Depreciation and amortization | 2,753 Millions of yen |
| Breakdown of extraordinary income (loss) | Extraordinary income Insurance proceeds received 50 Millions of yen / Extraordinary loss Special investigation expenses and related costs 650 Millions of yen, Provision for litigation loss 11 Millions of yen, Other 46 Millions of yen |
| Disclosure regarding the going concern assumption | Not applicable. |
| Change in accounting policy | Changes due to revisions to standards Yes / Other changes No / Change in accounting estimate No / Restatement No |
| Changes in the scope of consolidation | New Number of companies 1 / Company name 株式会社ミドリ / Excluded Number of companies 0 / Company name Not disclosed |
| Material subsequent events | Not applicable. |
| Availability of Supplementary Financial Results Materials | Yes |
| Availability of Financial Results Briefing | Event Yes / Subject person Institutional investors and analysts; individual investors |
| Issued Shares at Period-End | 98,112,000 |
| Treasury Shares at Period-End | 578,157 |
| Factors Behind Changes in Business Performance | 医心館事業で新たに29事業所を開設し、1事業所を増床した一方、「医心館 本郷」を閉鎖し、「医心館 姫路」を事業譲渡した。次期計画では、新設施設の業績貢献と既存施設稼働率の回復を見込む一方、人件費増等の費用増や診療報酬改定影響を考慮している。 |
Items this document does not state (7)
Revision to Earnings ForecastShareholder Return PolicySegment revenueSegment profitRegional salesOrders received and order backlogImpairment loss
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.当期について、医心館事業で29事業所を新設し、1事業所を増床した一方、1事業所を閉鎖し、1事業所を事業譲渡したと説明している。次期については、新設施設の業績貢献や既存施設稼働率の回復を見込む一方、人件費増等の費用増や診療報酬改定の影響を考慮して保守的に計画している。
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.